|
See related Menopur powd for inj information |
|
|
|
Manufacturer |
Ferring |
|
Distributor |
Pacific Healthcare |
|
Contents |
Highly purified menotrophin corresponding to 75 IU FSH & 75 IU LH |
|
Indications |
Stimulation of follicular growth in females w/ hypo- or normogonadotropic ovarian insufficiency. |
|
Dosage |
Individualised dosage. In general, initially 1-2 vials daily via IM/SC inj. Dose may be increased gradually until there is evidence of oestradiol secretion or follicular growth. Maintain dose until pre-ovulation oestradiol serum level is achieved. To induce ovulation, administer 5,000-10,000 IU HCG via IM inj 1-2 days after the last dose of Menopur. |
|
Contraindications |
Pregnancy & lactation. Ovarian or cyst enlargement not caused by polycystic ovarian syndrome, gynaecological bleeding of unknown origin, uterine, ovarian or breast cancers. |
|
Special Precautions |
Ovarian activity should be checked prior to administration. Treatment should be immediately discontinued if unintentional hyperstimulation occurs. Pregnancies that occur after fertility treatment w/ gonadotrophins are more likely to be terminated in spontaneous abortions than normal pregnancies. |
|
Adverse Drug Reactions |
Ovarian hyperstimulation, ascites, hydrothorax, oliguria, hypotension, thromboembolism, hypersensitivity reactions, fever, nausea & vomiting, inj site reactions, unintentional multiple pregnancies.
View ADR Monitoring Form |
|
Pregnancy Category (US FDA) |
Category X: Studies in animals or human beings have demonstrated foetal abnormalities or there is evidence of foetal risk based on human experience or both, and the risk of the use of the drug in pregnant women clearly outweighs any possible benefit. The drug is contraindicated in women who are or may become pregnant. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Menopur powder for injection |
|
|
|
Manufacturer: |
Ferring |
|
Distributor: |
Pacific Healthcare
|
|
|
|
